Metacrine, Inc.
MTCRDelisted Mar 3, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001634379
Metacrine, Inc. was delisted on Mar 3, 2023; its insiders filed their last Form 4 on Mar 24, 2023; 29 institutions reported holding it in 13F filings for Q4 2022, worth $7.29M in total; no superinvestor held it.
Q4 2022 vs. Q3 2022
How the institutions holding Metacrine, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 27 | 29 | +2 |
| Shares | 8.11M | 16.3M | +8.17M (+100.8%) |
| Value | $3.93M | $7.29M | +$3.36M (+85.6%) |
New holders (7)
Institutions that held Metacrine, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BML Capital Management, LLC | 6,167,458 | $2.76M | 2.64% |
| Millennium Management LLC | 97,033 | $43.0K | 0.00% |
| Two Sigma Securities, LLC | 69,435 | $31.1K | 0.00% |
| Trifecta Capital Advisors, LLC | 4,000 | $1.79K | 0.00% |
| NewSquare Capital LLC | 600 | $269 | 0.00% |
| Allworth Financial LP | 500 | $224 | 0.00% |
| Bank of America Corp | 40 | $18 | 0.00% |
Sold out (5)
Institutions that held Metacrine, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| CSS LLC | 169,344 | $82.0K |
| Vivo Capital, LLC | 146,426 | $71.0K |
| Citadel Advisors LLC | 136,606 | $66.0K |
| Group One Trading, L.P. | 34,670 | $17.0K |
| JPMorgan Chase & Co | 3 | $0 |